Ada Patient Finder -- Daily Briefing

Monday, February 02, 2026 -- 10:54 AM ET
Snapshot: 2026-02-02
Pipeline Snapshot
€97,368,316
Total Pipeline (Unweighted)
€8,139,892
Weighted Pipeline
135
Open Opps
€0
Closing This Quarter
0
Calls Yesterday
4.0
7-Day Avg Calls
130
Stale Deals
Stage Moves (Last 24h)
Pfizer - Nurtec Advanced
Moved from Proposal | 30% to Discovery | 10% (Eran Desheh)
€500,000
Pipeline Changes
No pipeline changes
Stale Deals (14+ Days in Stage)
Bayer | ATTR-CM | DE 341 Days Stale
Jacob Plummer | Qualification | 5% | €422,074
BMS - US 341 Days Stale
Jacob Plummer | Qualification | 5% | €422,074
EMD Serono | MS & Rare Disease | US 341 Days Stale
Eran Desheh | Qualification | 5% | €422,074
Merck Patient Finder PAH(Oncology) Winrevair US 340 Days Stale
Karen VanOverberghe | Qualification | 5% | €422,074
Progyny | Endometriosis | US 339 Days Stale
Jacob Plummer | Qualification | 5% | €422,074
TAKEDA | Psoriasis & Psoriatic Arthritis (Phase 3)| US 339 Days Stale
Eran Desheh | Qualification | 5% | €422,074
Takeda | Narcolepsy | investigational | US 321 Days Stale
Eran Desheh | Discovery | 10% | €422,074
Trinity Life Sciences Exploration 317 Days Stale
Jacob Plummer | Qualification | 5% | €422,074
VERTEX | AMKD | US 315 Days Stale
Ashley Cudini | Discovery | 10% | €422,074
Centene Patient Finder 314 Days Stale
Jacob Plummer | Qualification | 5% | €422,074
+120 more stale deals
No Decision Maker Engaged
All tracked deals have decision maker contact
Flagged Calls (< 3.0)
No flagged calls
Calls Yesterday (0)
No calls recorded yesterday
Top Deals by Value
GNAL
Qualification | 5%
€20,500,000
Biogen | Friedreichs Ataxia | Global - Phase 2
Qualification | 5%
€6,000,000
Blue Shield of California
Proposal | 30%
€5,486,968
Alberta Health Services - Patient Portal (via Orion & Telus/IBM)
Qualification | 5%
€4,796,825
Resmed Phase 2
Qualification | 5%
€2,532,447
SANOFI | Diabetes | TZIELD | US - Phase 2
Discovery | 10%
€2,532,447
Biogen Germany FA extension
Discovery | 10%
€2,100,000
Blue Cross Blue Shield Arizona
Qualification | 5%
€1,435,053
Pharma Intel -- Urgent
None identified based on recent news.
Meetings Today
9:00 AM -- Weißflog, Sebastian, Vahsen, Timo
Ada
10:00 AM -- jacob.plummer@ada.com, randal.whitmore@ext.ada.com, graham.french@ada.com, shireen.saxena@ada.com
Weekly ELT meeting
12:00 PM -- craigdbryant@yahoo.com
Daniel / Craig Bryant
2:00 PM
Strategy Block
2:30 PM -- Jeff Keswin <jkeswin@lyricalpartners.com>, Rob Keve <rkeve@rolejody.com>, Benjamin Gordon, dan@trovario.com
YPO February 2026
Generated by Ada Cockpit | 2026-02-02 10:54 ET